These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7142926)

  • 21. Colorectal cancer screening.
    Cardinal PA
    Am Fam Physician; 1986 Sep; 34(3):41-2, 47, 49. PubMed ID: 3751850
    [No Abstract]   [Full Text] [Related]  

  • 22. Reasons for failure to diagnose colorectal carcinoma at colonoscopy.
    Leaper M; Johnston MJ; Barclay M; Dobbs BR; Frizelle FA
    Endoscopy; 2004 Jun; 36(6):499-503. PubMed ID: 15202045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Randomized population study of screening for intestinal cancer with Hemoccult-II].
    Kronborg O; Fenger C; Olsen J; Jørgensen OD; Søndergaard O
    Ugeskr Laeger; 1997 Aug; 159(33):4977-81. PubMed ID: 9281212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Colorectal cancer screening in Massachusetts: measuring compliance with current guidelines.
    Erban S; Zapka J; Puleo E; Vickers-Lahti M
    Eff Clin Pract; 2001; 4(1):10-7. PubMed ID: 11234181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Practical experiences with the stool test for occult blood].
    Gnauck R
    Schweiz Med Wochenschr; 1983 Apr; 113(15):528-34. PubMed ID: 6857203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Rectoscopy and Hemoccult-II as initial diagnosis. A procedure in patients with symptoms of irritable colon].
    Jensen BM; Holtved E; Kronborg O; Nørgård JR; Fenger C
    Ugeskr Laeger; 1994 Aug; 156(34):4795-7, 4800. PubMed ID: 7992411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serial Hemoccult stool screening for colorectal cancer.
    Gardner SS; Messner RL; Webb DD
    W V Med J; 1985 Jan; 81(1):5-10. PubMed ID: 3855578
    [No Abstract]   [Full Text] [Related]  

  • 28. The use of screening colonoscopy for patients cared for by the Department of Veterans Affairs.
    El-Serag HB; Petersen L; Hampel H; Richardson P; Cooper G
    Arch Intern Med; 2006 Nov; 166(20):2202-8. PubMed ID: 17101937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A population-based, community estimate of total colon examination: the impact on compliance with screening for colorectal cancer.
    Schoen RE; Weissfeld JL; Trauth JM; Ling BS; Hayran M
    Am J Gastroenterol; 2002 Feb; 97(2):446-51. PubMed ID: 11866286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimal dietary conditions for hemoccult testing.
    Macrae FA; St John DJ; Caligiore P; Taylor LS; Legge JW
    Gastroenterology; 1982 May; 82(5 Pt 1):899-903. PubMed ID: 7060911
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Colorectal cancer screening among first-degree relatives of colorectal cancer patients: benefits and barriers.
    Mack LA; Cook LS; Temple WJ; Carlson LE; Hilsden RJ; Paolucci EO
    Ann Surg Oncol; 2009 Aug; 16(8):2092-100. PubMed ID: 19479307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Five-year follow-up of asymptomatic patients with negative fecal occult blood test results in whom clinically significant colorectal pathology was detected.
    Cauffman JG; Forsyth RA; Lapsys FX; Clark V
    Am J Gastroenterol; 1997 Nov; 92(11):2036-9. PubMed ID: 9362187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis and management of colorectal cancer.
    Simon JB
    Compr Ther; 1986 Aug; 12(8):15-9. PubMed ID: 3742993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Test for blood in the stool using slides impregnated with guaïac. Possible application to the prevention and detection of colo-rectal cancers].
    Paillot B; Colin R; Le Grix A
    Med Chir Dig; 1978; 7(1):43-6. PubMed ID: 642625
    [No Abstract]   [Full Text] [Related]  

  • 35. Screening for colorectal neoplasms. A comparison of the fecal occult blood test and endoscopic examination.
    Letsou G; Ballantyne GH; Zdon MJ; Zucker KA; Modlin IM
    Dis Colon Rectum; 1987 Nov; 30(11):839-43. PubMed ID: 3677957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Early detection of colorectal cancers by detection of occult blood in feces using Krypto-Haem SSW].
    Uhlig K; Lampe J; Jacobasch KH
    Z Gesamte Inn Med; 1986 Dec; 41(23):660-3. PubMed ID: 3577258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screen compliance rates in 14-years annual screening program for colorectal cancer with immunochemical fecal occult blood test-- identification of higher priority subjects in health education.
    Wei N; Nakama H; Li T
    Eur J Med Res; 1998 Jul; 3(7):341-4. PubMed ID: 9682030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progress report on controlled trial of fecal occult blood testing for the detection of colorectal neoplasia.
    Winawer SJ; Andrews M; Flehinger B; Sherlock P; Schottenfeld D; Miller DG
    Cancer; 1980 Jun; 45(12):2959-64. PubMed ID: 6992968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High compliance rates observed for follow up colonoscopy post polypectomy are achievable outside of clinical trials: efficacy of polypectomy is not reduced by low compliance for follow up.
    Colquhoun P; Chen HC; Kim JI; Efron J; Weiss EG; Nogueras JJ; Vernava AM; Wexner SD
    Colorectal Dis; 2004 May; 6(3):158-61. PubMed ID: 15109378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An adapted program of colorectal cancer screening--7 years experience and cost-benefit analysis.
    Fric P; Zavoral M; Dvoráková H; Zoubek V; Roth Z
    Hepatogastroenterology; 1994 Oct; 41(5):413-6. PubMed ID: 7851847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.